Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hidden chemicals in your home may affect weight loss, new study suggests

NCT ID NCT07560579

Knowledge-focused Sponsor: Million Marker Wellness, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 19, 2026 · Updated 4 times

Summary

This study looks at whether reducing exposure to everyday chemicals called endocrine disruptors (found in plastics, cosmetics, and food) can help people with overweight or obesity lose weight. About 226 participants will either follow a program to lower chemical exposure or use a standard weight loss app. Researchers will measure weight changes and chemical levels in urine and blood to see which approach works better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Educational curriculum on reducing EDC exposure and a weight loss application
What this could lead to
If successful, this could show that reducing everyday chemical exposures helps people lose weight, pointing toward new weight management strategies.
What could go wrong
This is an early-stage study with no blinding, and results may not apply to everyone. The interventions are behavioral, so outcomes depend heavily on participant adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

226 people

The number who actually took part.

Started

Aug 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * BMI over 25 * Not pregnant or breast feeding * Do not have diabetes, kidney disease, liver disease, cardiac disease, pulmonary disease or cancer. * Do not smoke * Not in another weight loss program or on GLP-1 * Have access to a smartphone or computer Exclusion Criteria: * BMI under 25 * Pregnant or breast feeding * Have diabetes, kidney disease, liver disease, cardiac disease, pulmonary disease or cancer. * Smoke * In another weight loss program or on GLP-1 * Do not have access to a smartphone or computer

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Environmental exposure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Environmental exposure Obesity & overweight Overweight (bmi > 25)

Contacts and locations

Locations

  • Million Marker

    Berkeley, California, 94704, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.